BRAMPTON, ON, Oct. 25, 2021 /CNW/ - Medtronic Canada ULC,
a subsidiary of Medtronic plc (NYSE: MDT) – a global leader in
healthcare technology, today announced the commercial launch of the
Mazor™ X System (herein referred to as Mazor) for
robotic-guided spine surgery. The Mazor platform offers a fully
integrated procedural solution for surgical planning, workflow,
execution and confirmation, and is the first dedicated robotic
assisted spine surgery platform being launched in Canada.
The Mazor platform seamlessly incorporates existing
StealthStation™ S8 surgical navigation capabilities into the Mazor
Core Technology robotic-assisted surgery platform. Real-time image
guidance, visualization and navigation are informed by interactive
3D planning and information systems to deliver workflow
predictability and flexibility for procedures.
"The integration of navigation and robotic technologies into one
platform is an exciting advancement in the field of spinal
surgery," says Dr. Scott Paquette,
orthopedic spine surgeon, and president of the Canadian Spine
Society. "Mazor represents an incredible future of possibilities in
spinal robotics, which I believe will greatly contribute to reduced
risk for patients."
The three-dimensional Mazor platform allows surgeons to quickly
visualize anatomy and spinal structures in relation to one another.
This provides surgeons with access to plan and simulate spinal
cages and screws in advance, with the goal of increasing
efficiencies and surgical precision.
The best-in-class Midas Rex™ MR8 Electric High Speed Drill
Systems are fully integrated throughout the Mazor system, enabling
improved trajectory precision starting with pilot hole creation and
offering attachments and dissecting tools designed to drill with
accuracy at speeds up to 75,000 rpm. Surgeons can now use navigated
interbody features on the Mazor system to visualize disc prep and
interbody placement during a robotic procedure.
"Mazor embodies a synergy between robotics and navigation,
providing a rigorous degree of accuracy integrated throughout the
surgical procedure, with the hope of producing more reliable
outcomes,"1 says Peter
Tomashewski, senior director, Neuro and Spine Surgery,
within the Cranial & Spinal Technologies business at Medtronic
Canada. "The addition of Mazor to our portfolio provides another
transformative tool that elevates our value driven solutions for
spinal care."
Learn more at medtronic.ca/mazor
About Medtronic Canada ULC
Bold thinking. Bolder
actions. We are Medtronic. Proud to serve Canadian healthcare for
over 50 years, Medtronic Canada ULC is headquartered in
Brampton, Ontario, with regional
offices in Montreal and
Vancouver, and is a subsidiary of
Medtronic plc. We are the leading global healthcare technology
company that boldly attacks the most challenging health problems
facing humanity by searching out and finding solutions. Our Mission
— to alleviate pain, restore health, and extend life — unites a
global team of 90,000+ passionate people. Our technologies and
therapies address 70 health conditions and include cardiac devices,
surgical robotics, insulin pumps, surgical tools, patient
monitoring systems, and more. Powered by our diverse knowledge,
insatiable curiosity, and desire to help all those who need it, we
deliver innovative technologies that transform the lives of two
people every second, every hour, every day. Expect more from us as
we empower insight-driven care, experiences that put people first,
and better outcomes for all. In everything we do, we are
engineering the extraordinary. For more information on Medtronic
Canada, visit www.Medtronic.ca and follow @MedtronicCA on
Twitter and LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
1 Data on File.
SOURCE Medtronic Canada ULC